Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C

Blood

Volumn 87, Issue 6, 1996, Pages 2292-2300

  Koppelman, Stefan J ^a   Van Hoeij, Maggy ^b   Vink, Tom ^b   Lankhof, Hanneke ^b   Schiphorst, Marion E ^b   Damas, Conchi ^b   Vlot, André J ^b   Wise, Robert ^b   Bouma, Bonno N ^b   Sixma, Jan J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; PROTEIN C; VON WILLEBRAND FACTOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD CLOTTING; ENZYME ACTIVATION; HEMOPHILIA A; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION;

EID: 13344276582     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.6.2292.bloodjournal8762292     Document Type: Article

References (47)

1. Van-Dieijen G, Tans G, Rosing J, Hemker HC: The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 256:3433, 1981
2. Rizza CR: Haemophilia and related inherited coagulation defects, in Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds): Haemostasia and Thrombosis. Edinburgh, UK, Churchill Livingstone, 1994, p 819
3. Sakariassen KS, Bolhuis PA, Sixma JJ: Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279:636, 1979
4. Wagner DD: Cell biology of von Willebrand factor. Ann Rev Cell Biol 6:217, 1990
5. Fay PJ, Kawai Y, Wagner DD, Ginsburg D, Bonthron DT, Ohlsson-Wilhelm BM, Chavin SI, Abraham GN, Handin RI, Orkin SH, Montgomery RR, Marder VJ: Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science 232:995, 1986
6. Wise RJ, Pittman DD, Handin RI, Kaufman RJ, Orkin SH: The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52:229, 1988
7. Leyte A, Voorberg J, Van Schijndel HB, Duim B, Pannekoek H, van Mourik JA: The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor. Biochem J 274:257, 1991
8. Wise RJ, Dorner AJ, Krane M, Pittman DD, Kaufman RJ: The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem 266:21948, 1991
9. Weiss HJ, Sussman II, Hoyer LW: Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 60:390, 1977
10. Over J, Sixma JJ, Bouma BN, Bolhuis PA, Vlooswijk RA, Beeser-Visser NH: Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease. J Lab Clin Med 97:332, 1981
11. Brinkhous KM, Sandberg H, Garris JB, Mattsson C, Palm M, Griggs T, Read MS: Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 82.8752, 1985
12. Tuddenham EG, Lane RS, Rotblat F, Johnson AJ, Snape TJ, Middleton S, Kernoff PB: Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol 52:259, 1982
13. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS: A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem 262:8443, 1987
14. Piétu G, Ribba AS, Meulien P, Meyer D: Localization within the 106 N-terminal amino acids of von Willebrand factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIII. Biochem Biophys Res Commun 163:618, 1989
15. Bahou WF, Ginsburg D, Sikkink R, Litwiller R, Fass DN: A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide. J Clin Invest 84:56, 1989
16. Mazurier C: von Willebrand disease masquerading as haemophilia A. Thromb Haemost 67:391, 1992
17. Hoyer LW: The factor VIII complex: Structure and function. Blood 58:1, 1981
18. Ruggeri ZM, Zimmerman TS: von Willebrand factor and von Willebrand disease. Blood 70:895, 1987
19. Bloom AL: The biosynthesis of factor VIII. Clin Haematol 8:53, 1979
20. Vlot AJ, Koppelman SJ, van den Berg HM, Bouma BN, Sixma JJ: The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 85:3150, 1995
21. Marlar RA, Kleiss AJ, Griffin JH: Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 59:1067, 1982
22. Kisiel W, Canfield WM, Ericsson LH, Davie EW: Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 16:5824, 1977
23. Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenham EGD, Lawn RM, Capon DJ: Structure of human factor VIII. Nature 312:337, 1984
24. Di-Scipio RG, Hermodson MA, Yates SG, Davie EW: A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 16:698, 1977
25. DiScipio RG, Davie EW: Characterization of protein S, a gamma-carboxyglutamic acid containing protein from bovine and human plasma. Biochemistry 18:899, 1979
26. Gardiner JE, McGann MA, Berridge CW, Fulcher CA, Zimmerman TS, Griffin JH: Protein S as a cofactor for activated protein C in plasma and the inactivation of purified factor VIII:C. Circulation 70:205, 1984 (abstr)
27. Stenflo J, Jonsson M: Protein S, a new vitamin K-dependent protein from bovine plasma. FEBS Lett 101:377, 1979
28. Walker FJ: Regulation of activated protein C by protein S. The role of 1phospholipid in factor Va inactivation. J Biol Chem 256:11128, 1981
29. Shen L, Dahlback B: Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 269:18735, 1994
30. Koedam JA, Meijers JC, Sixma JJ, Bouma BN: Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 82:1236, 1988
31. Fay PJ, Coumans J, Walker FJ: von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem 266:2172, 1991
32. Nesheim M, Pittman DD, Giles AR, Fass DN, Wang JH, Slonosky D, Kaufman RJ: The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem 266:17815, 1991
33. Koedam JA, Beeser-Visser NH, Sixma JJ, Bouma BN. Two binding sites for factor VIII on von Willebrand factor exist. Discrepancy between binding of factor VIII and protection against activated protein C. Thromb Haemost 62:491, 1989 (abstr)
34. Layet S, Girma JP, Obert B, Peynaud-Debayle E, Bihoreau N, Meyer D: Evidence that a secundary binding and protection site for factor VIII on von Willebrand factor is highly unlikely. Biochem J 282:129, 1992
35. Wise RJ, Pittman DD, Handin RI, Kaufman RJ, Orkin SH: The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52:229, 1988
36. Yon J, Fried M: Precise gene fusion by PCR. Nucleic Acids Res 17:4895, 1989
37. Palmiter RD, Behringer RR, Quaife CJ, Maxwell F, Maxwell IH, Brinster RL: Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50:435, 1987
38. Lawrie AS, Hoser MJ, Savidge GF: Phast assessment of vWf:Ag multimeric distribution. Thromb Res 59:369, 1990
39. Fay PJ, Smudzin TM: Topography of the human factor VIII-von Willebrand factor complex. J Biol Chem 265:6197, 1990
40. Leatherbarrow RJ: Enzfitter. North Holland, Amsterdam, The Netherlands, Elsevier/Biosoft, 1987
41. Leyte A, Verbeet MP, Brodniewicz-Proba T, van-Mourik JA, Mertens K: The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. Biochem J 257:679, 1989
42. Fay PJ, Smudzin TM: Intersubunit fluorescence energy transfer in human factor VIII. J Biol Chem 264:14005, 1989
43. Vlot AJ, Koppelman SJ, Sixma JJ, Damas C, van den berg MH, Bouma BN, Willems GM: Kinetics of factor VIII-von Willebrand factor association. Blood 87:1809, 1996
44. Voorberg J, Fontijn R, Calafat J, Janssen H, van Mourik JA, Pannekoek H: Assembly and routing of von Willebrand factor variants: The requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids. J Cell Biol 113 195, 1991
45. Gilbert GE, Drinkwater D, Barter S, Clouse SB: Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). J Biol Chem 267:15861, 1992
46. Saenko EL, Shima M, Rajalakshmi KJ, Scandella D: A role for the C2 domain of factor VIII in binding to von Willebrand factor. J Biol Chem 269:11601, 1994
47. Marti T, Rosselet SJ, Titani K, Walsh KA: Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry 26:8099, 1987